Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hoffmann

Showing results (991-1000 of 1,122) with videos related to

Pageof 113
Sort By:
The Journal of Infectious Diseases|September 9, 1999
Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell functionZ q Wang, H W Horowitz, T Orlikowsky, et al.
Thrombosis Research|March 3, 2001
The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effectsD Gustafsson, J Nyström, S Carlsson, et al.
Frontiers in Cell and Developmental Biology|September 8, 2022
Comparison of plasma- and saliva-derived exosomal miRNA profiles reveals diagnostic potential in head and neck cancerLinda Hofmann, Tsima Abou Kors, Jasmin Ezić, et al.
Cancers|August 6, 2020
Circulating Exosomes Inhibit B Cell Proliferation and ActivityJan C Schroeder, Lisa Puntigam, Linda Hofmann, et al.
International Journal of Molecular Sciences|July 26, 2020
Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and ImmunotherapyLisa K Puntigam, Sandra S Jeske, Marlies Götz, et al.
Neoplasia (New York, N.Y.)|November 28, 2024
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cellsAdrian Fehn, Adrian von Witzleben, Ayla Grages, et al.
Laryngo- Rhino- Otologie|June 2, 2023
[Recommendations of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC) for the granting of resident training program authorizations]Orlando Guntinas-Lichius, Stephan Lang, Timo Stöver, et al.
Diabetologia|April 28, 2007
A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2K Hoffmann, M Mattheisen, S Dahm, et al.
International Journal of Molecular Sciences|December 23, 2022
Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment DecisionsAdrian von Witzleben, Urs Müller-Richter, Katja Maurus, et al.
Journal of Translational Medicine|August 23, 2011
Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomasChristoph Bergmann, Hagen S Bachmann, Agnes Bankfalvi, et al.
Pageof 113

Showing results (991-1000 of 1,122) with videos related to

Sort By:
Pageof 113
The Journal of Infectious Diseases|September 9, 1999
Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell functionZ q Wang, H W Horowitz, T Orlikowsky, et al.
Thrombosis Research|March 3, 2001
The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effectsD Gustafsson, J Nyström, S Carlsson, et al.
Frontiers in Cell and Developmental Biology|September 8, 2022
Comparison of plasma- and saliva-derived exosomal miRNA profiles reveals diagnostic potential in head and neck cancerLinda Hofmann, Tsima Abou Kors, Jasmin Ezić, et al.
Cancers|August 6, 2020
Circulating Exosomes Inhibit B Cell Proliferation and ActivityJan C Schroeder, Lisa Puntigam, Linda Hofmann, et al.
International Journal of Molecular Sciences|July 26, 2020
Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and ImmunotherapyLisa K Puntigam, Sandra S Jeske, Marlies Götz, et al.
Neoplasia (New York, N.Y.)|November 28, 2024
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cellsAdrian Fehn, Adrian von Witzleben, Ayla Grages, et al.
Laryngo- Rhino- Otologie|June 2, 2023
[Recommendations of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC) for the granting of resident training program authorizations]Orlando Guntinas-Lichius, Stephan Lang, Timo Stöver, et al.
Diabetologia|April 28, 2007
A German genome-wide linkage scan for type 2 diabetes supports the existence of a metabolic syndrome locus on chromosome 1p36.13 and a type 2 diabetes locus on chromosome 16p12.2K Hoffmann, M Mattheisen, S Dahm, et al.
International Journal of Molecular Sciences|December 23, 2022
Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment DecisionsAdrian von Witzleben, Urs Müller-Richter, Katja Maurus, et al.
Journal of Translational Medicine|August 23, 2011
Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomasChristoph Bergmann, Hagen S Bachmann, Agnes Bankfalvi, et al.
Pageof 113